More on ZLAB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-69.7% Growth)
- Ratings (8.6 Score)
- Holders

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Zai Lab Limited (NQ:ZLAB)
Delayed: 23.19 -0.32 (1.36%)
Prev. Close $23.51  
Open$24.55 
52 Wk High$ 
52 Wk Low$ 
Day High$24.64 
Day Low$23.14 
P/E N/A  
EPS$ 
Volume843,231 

Friends, Peers and Foes (?): 1ZLB, S1GE34, RMD, ACLX, AGIO (more...)

Oct 14, 2026 07:01 AM Zai Lab to share first ZL-1503 clinical data at ACAAI 2026
Oct 14, 2026 07:00 AM Zai Lab to Present Data From First Clinical Trial Evaluating ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, for Atopic Diseases
Oct 6, 2026 07:42 AM Zai Lab (ZLAB) Reiterated at Overweight by Cantor Fitzgerald
Oct 5, 2026 04:45 PM Form 4 Zai Lab Ltd For: Oct 01 Filed by: Chen Yajing
Sep 29, 2026 07:00 AM Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Aug 27, 2026 08:33 AM Zai Lab (ZLAB) PT Raised to $36 at JPMorgan
Aug 20, 2026 04:20 PM Form 144 Zai Lab Ltd Filed by: Smiley Joshua L
Aug 19, 2026 01:51 PM Form 144 Zai Lab Ltd Filed by: Chen Yajing
Aug 17, 2026 06:00 AM Zai Lab and argenx report Phase 3 trial win for myositis drug
Aug 17, 2026 06:00 AM Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
View All Articles

Entities mentioned with ZLAB

View All Entities